Skip to content
Study details
Enrolling now

Vagus Nerve Stimulation (VNS) as a Treatment for Fibromyalgia Patients

Massachusetts General Hospital
NCT IDNCT06009159ClinicalTrials.gov data as of Apr 2026
Target enrollment

60

Study length

about 2.3 years

Ages

18–80

Locations

1 site in MA

Why this study is shown

Matches fibromyalgiaActively enrolling

What this study is about

Researchers are testing whether vagus nerve stimulation can improve pain and related symptoms in people with fibromyalgia. The treatment involves using a device to stimulate the vagus nerve. The trial will last approximately 852 days.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Use Transcutaneous Vagus Nerve Stimulation

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
Randomized & Blinded

You may get a placebo/standard care, and you won't know which.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Endpoints

Primary: A modified McGill Pain Questionnaire

Secondary: Blood inflammation marker, Medical Outcomes Study Questionnaire Short Form 36, Medical Outcomes Study Sleep Scale, Multidimensional Fatigue Inventory

Devices

therapeutic

Body systems

Musculoskeletal